Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs

Health

Wegovy-Maker Novo Faces Calls To Map Out Strategy Beyond Weight-Loss Drugs

By reuters.com

Novo rode a wave of demand after launching Wegovy in 2021 which helped it become Europe's most valuable listed firm in 2023 with a market capitalisation of more than $600 billion. Sign up here. However, Novo's share price has plunged by more than 70% ...Read more

Related Posts

Testosterone scripts for women rise, along with denials and delays

Testosterone scripts for women rise, along with denials and delays

Sep 17, 2026
Osteoporosis drugs linked to lower Alzheimer's disease and dementia risk

Osteoporosis drugs linked to lower Alzheimer's disease and dementia risk

Sep 16, 2026
FDA examines use of testosterone prescriptions for menopause

FDA examines use of testosterone prescriptions for menopause

Sep 18, 2026
Tuberculosis case confirmed at high school in Cumberland Co., more than 260 others possibly exposed

Tuberculosis case confirmed at high school in Cumberland Co., more than 260 others possibly exposed

Sep 16, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.